Literature DB >> 19822810

Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome.

Matthew A Levin1, Hung-Mo Lin, Javier G Castillo, David H Adams, David L Reich, Gregory W Fischer.   

Abstract

BACKGROUND: Vasoplegic syndrome is a form of vasodilatory shock that can occur after cardiopulmonary bypass (CPB). We hypothesized that the severity and duration of the decline in mean arterial pressure immediately after CPB is begun can be used as a predictor of patients will develop vasoplegia in the immediate post-CPB period and of poor clinical outcome. We quantified the decline in mean arterial pressure by calculating an area above the mean arterial blood pressure curve. METHODS AND
RESULTS: We retrospectively analyzed 2823 adult cardiac surgery cases performed between July 2002 and December 2006. Of these 2823, 577 (20.4%) were vasoplegic after separation from CPB. We found that 1645 patients (58.3%) had a clinically significant decline in mean arterial pressure after starting CPB (area above the mean arterial blood pressure curve >0) and were significantly more likely to become vasoplegic (23.0% versus 16.9%; odds ratio, 1.26; 95% confidence interval, 1.12 to 1.43; P<0.001). These patients were also far more likely either to die in hospital or to have a length of stay >10 days (odds ratio, 3.30; 95% confidence interval, 1.44 to 7.57; P=0.005). Additional risk factors for developing vasoplegia that were identified included the additive euroSCORE, procedure type, prebypass mean arterial pressure, length of bypass, administration of pre-CPB vasopressors, core temperature on CPB, pre- and post-CPB hematocrit, the preoperative use of beta-blockers or angiotensin-converting enzyme inhibitors, and the intraoperative use of aprotinin.
CONCLUSIONS: The results of this investigation suggest that it is possible to predict vasoplegia intraoperatively before separation from CPB and that the presence of a clinically significant area above the mean arterial blood pressure curve serves as a predictor of poor clinical outcome.

Entities:  

Mesh:

Year:  2009        PMID: 19822810     DOI: 10.1161/CIRCULATIONAHA.108.814533

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  26 in total

1.  Risk assessment and outcomes of vasoplegia after cardiac surgery.

Authors:  Athanasios Tsiouris; Lynn Wilson; Ala S Haddadin; James J Yun; Abeel A Mangi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-06-13

2.  Mast cell activation and arterial hypotension during proximal aortic repair requiring hypothermic circulatory arrest.

Authors:  Miklos D Kertai; Sreekanth Cheruku; Wenjing Qi; Yi-Ju Li; G Chad Hughes; Joseph P Mathew; Jörn A Karhausen
Journal:  J Thorac Cardiovasc Surg       Date:  2016-09-14       Impact factor: 5.209

3.  Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival.

Authors:  J Hunter Mehaffey; Lily E Johnston; Robert B Hawkins; Eric J Charles; Leora Yarboro; John A Kern; Gorav Ailawadi; Irving L Kron; Ravi K Ghanta
Journal:  Ann Thorac Surg       Date:  2017-05-24       Impact factor: 4.330

4.  A pilot goal-directed perfusion initiative is associated with less acute kidney injury after cardiac surgery.

Authors:  J Trent Magruder; Todd C Crawford; Herbert Lynn Harness; Joshua C Grimm; Alejandro Suarez-Pierre; Chad Wierschke; Jim Biewer; Charles Hogue; Glenn R Whitman; Ashish S Shah; Viachaslau Barodka
Journal:  J Thorac Cardiovasc Surg       Date:  2016-09-19       Impact factor: 5.209

5.  Monitoring dynamic arterial elastance as a means of decreasing the duration of norepinephrine treatment in vasoplegic syndrome following cardiac surgery: a prospective, randomized trial.

Authors:  Pierre-Grégoire Guinot; Osama Abou-Arab; Mathieu Guilbart; Stéphane Bar; Elie Zogheib; Mona Daher; Patricia Besserve; Joseph Nader; Thierry Caus; Said Kamel; Hervé Dupont; Emmanuel Lorne
Journal:  Intensive Care Med       Date:  2017-01-24       Impact factor: 17.440

6.  The incidence of vasoplegia in adult patients with right-sided congenital heart defects undergoing cardiac surgery and the correlation with serum vasopressin concentrations.

Authors:  Erica D Wittwer; James J Lynch; William C Oliver; Joseph A Dearani; Harold M Burkhart; William J Mauermann
Journal:  J Thorac Cardiovasc Surg       Date:  2013-11-23       Impact factor: 5.209

7.  Pre-existing endothelial cell activation predicts vasoplegia after mitral valve surgery.

Authors:  Kirsten A Kortekaas; Jan H N Lindeman; Marlies E J Reinders; Meindert Palmen; Robert J M Klautz; Philip G de Groot; Mark Roest
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-06-04

8.  A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.

Authors:  Joshua Manghelli; Lisa Brown; Hany B Tadros; Nabil A Munfakh
Journal:  Tex Heart Inst J       Date:  2015-10-01

9.  Neuroendocrine predictors of vasoplegia after cardiopulmonary bypass.

Authors:  D Pasero; A M Berton; G Motta; R Raffaldi; G Fornaro; A Costamagna; A Toscano; C Filippini; G Mengozzi; N Prencipe; M Zavattaro; F Settanni; E Ghigo; L Brazzi; A S Benso
Journal:  J Endocrinol Invest       Date:  2020-11-27       Impact factor: 4.256

10.  Major themes for 2009 in cardiothoracic and vascular anesthesia.

Authors:  J Fassl; H Riha; H Ramakrishna; N Singh; T Wyckoff; C Roscher; J G T Augoustides
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.